Discovery suggests new way to target mantle cell lymphoma

A new study shows that blocking a certain protein's interaction with mantle cell lymphoma slows the growth of this cancer.

Machine learning gives nuanced view of Alzheimer’s stages

A Cornell-led collaboration used machine learning to pinpoint the most accurate means, and timelines, for anticipating the advancement of Alzheimer’s disease.

Appel ’53, vice chair of Weill Cornell Medicine board, dies at 91

Robert J. “Bob” Appel ’53, a vice chair of Weill Cornell Medicine’s Board of Fellows, Cornell trustee emeritus and presidential councillor, died Nov. 19 in New York, at age 91.

Cornell, global partners discuss the next ‘grand challenge’

More than 300 faculty, staff and students from Cornell and the new Cornell Global Hubs gathered Nov. 16-17 to discuss ideas for the next universitywide Global Grand Challenge.

Unusual antibody type shows ultrapotent activity against Zika

The discovery could lead to the development of therapies to protect babies from the potentially devastating effects of this disease. 

To prevent the next pandemic, restore wildlife habitats

Preserving and restoring natural habitats could prevent pathogens that originate in wildlife from spilling over into domesticated animals and humans, according to two new companion studies.

Personal sensing at work: tracking burnout, balancing privacy

Personal sensing data could help monitor and alleviate stress among resident physicians, although privacy concerns over who sees the information and for what purposes must be addressed, according to collaborative research from Cornell Tech.

Dr. Francis Lee named interim dean of Weill Cornell Medicine

The Cornell Board of Trustees and Weill Cornell Medicine Board of Fellows have approved the appointment of Dr. Francis Lee as interim dean of Weill Cornell Medicine and interim provost for medical affairs.

Faulty DNA repair may lead to BRCA-linked cancers

New research offers insight as to why individuals who inherit a mutation in one copy of the BRCA1 gene often develop mutations in their remaining normal copy of the BRCA1 gene, setting the stage for tumors to develop.